Previous 10 | Next 10 |
home / stock / pclof / pclof news
2023-11-29 10:23:36 ET More on PharmaCielo Financial information for PharmaCielo For further details see: PharmaCielo GAAP EPS of -C$0.02, revenue of C$352M
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) (" PharmaCielo " or the " Company "), the Canadian parent of Colombia's premier cultivator and producer o...
Today the Company closed the latest tranche consisting of 1,500 units for aggregate proceeds of $1,500,000. The Company also announced that it has agreed to issue shares and debt in settlement of certain amounts owing. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - October 6, 2023)...
2023-08-29 10:19:09 ET PharmaCielo press release ( OTCPK:PCLOF ): Q2 GAAP EPS of -C$0.02. Revenue of C$160,000 vs C$2.12M a year ago. For further details see: PharmaCielo GAAP EPS of -C$0.02
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) (" PharmaCielo " or the " Company "), the Canadian parent of Colombia's premier cultivator and producer of ...
2023-07-11 11:54:41 ET PharmaCielo ( OTCPK:PCLOF ) said on Tuesday that it had appointed Marc Lustig as chairman and chief executive officer. Lustig succeeds Bill Petron, who will continue to remain on the company's board on directors. Lustig has served as the lead direct...
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 11, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia ...
2023-05-29 07:42:10 ET PharmaCielo press release ( OTCPK:PCLOF ): Q1 GAAP EPS of -C$0.02. Revenue of C$0.79M (-34.2% Y/Y). For further details see: PharmaCielo GAAP EPS of -C$0.02, revenue of C$0.79M
The Company has products in various stages of testing and sales with more than 40 customers in 11 countries, with continued growth expected for the year. Q1 2023 revenue of $786,498; Adjusted EBITDA loss of $1.9 million. PharmaCielo continues to focus on operating efficiently, with overhead exp...
Represents PharmaCielo's first shipment to South Africa, which has well-established export networks in the UK and Australia, and other potential markets, globally. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 16, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCi...
News, Short Squeeze, Breakout and More Instantly...
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colomb...
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colomb...
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 4, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) (" PharmaCielo " or the " Company "), the Canadian parent of Colombia's premier cultivator and produce...